Funding for this research was provided by:
National Eye Institute (P30 EY014801, K23EY026118)
Research to Prevent Blindness (-)
Received: 10 January 2020
Accepted: 3 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: This study was approved by the University of Miami Institutional Review Board (ID 20180699).
: Not applicable.
: Taher Eleiwa and Eyup Ozcan: Nothing to declare.Mohamed Abou Shousha and Amr Elsawy: United States Non-Provisional Patents (Application No. 8992023 and 61809518), and PCT/US2018/013409. Patents and PCT are owned by University of Miami and licensed to Resolve Ophthalmics, LLC. Mohamed Abou Shousha is an equity holder and sits on the Board of Directors for Resolve Ophthalmics, LLC, and is consultant of Avedro.